Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Phase Ia trial of simeprevir in healthy volunteers

Trial Profile

Phase Ia trial of simeprevir in healthy volunteers

Completed
Phase of Trial: Phase I

Latest Information Update: 01 Oct 2007

At a glance

  • Drugs Simeprevir (Primary)
  • Indications Hepatitis C
  • Focus Adverse reactions; Pharmacokinetics
  • Sponsors Janssen R&D Ireland; Medivir AB
  • Most Recent Events

    • 01 Oct 2007 Results to be presented at AASLD 2007.
    • 13 Feb 2007 Status change
    • 27 Dec 2006 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top